6-30071128-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025236.4(RNF39):āc.1042G>Cā(p.Val348Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00029 in 1,553,876 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025236.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNF39 | NM_025236.4 | c.1042G>C | p.Val348Leu | missense_variant | 4/4 | ENST00000244360.8 | |
RNF39 | NM_170769.3 | c.844G>C | p.Val282Leu | missense_variant | 5/5 | ||
RNF39 | XM_017011325.2 | c.787G>C | p.Val263Leu | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNF39 | ENST00000244360.8 | c.1042G>C | p.Val348Leu | missense_variant | 4/4 | 1 | NM_025236.4 | P1 | |
RNF39 | ENST00000376751.8 | c.844G>C | p.Val282Leu | missense_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000292 AC: 51AN: 174822Hom.: 1 AF XY: 0.000235 AC XY: 22AN XY: 93616
GnomAD4 exome AF: 0.000295 AC: 413AN: 1401512Hom.: 35 Cov.: 30 AF XY: 0.000256 AC XY: 177AN XY: 690830
GnomAD4 genome AF: 0.000249 AC: 38AN: 152364Hom.: 1 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.1246G>C (p.V416L) alteration is located in exon 4 (coding exon 4) of the RNF39 gene. This alteration results from a G to C substitution at nucleotide position 1246, causing the valine (V) at amino acid position 416 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at